BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrelli F, Ghidini M, Ghidini A, Sgroi G, Vavassori I, Petrò D, Cabiddu M, Aiolfi A, Bonitta G, Zaniboni A, Rausa E. Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis. Surg Today 2021. [PMID: 33389174 DOI: 10.1007/s00595-020-02192-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Mispelbaum R, Hattenhauer ST, Brossart P, Heine A. Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors. Front Immunol 2022;13:976011. [DOI: 10.3389/fimmu.2022.976011] [Reference Citation Analysis]
2 Danilatou V, Nikolakakis S, Antonakaki D, Tzagkarakis C, Mavroidis D, Kostoulas T, Ioannidis S. Outcome Prediction in Critically-Ill Patients with Venous Thromboembolism and/or Cancer Using Machine Learning Algorithms: External Validation and Comparison with Scoring Systems. IJMS 2022;23:7132. [DOI: 10.3390/ijms23137132] [Reference Citation Analysis]
3 Ripollés-melchor J, Abad-motos A, Zorrilla-vaca A. Enhanced Recovery After Surgery (ERAS) in Surgical Oncology. Curr Oncol Rep. [DOI: 10.1007/s11912-022-01282-4] [Reference Citation Analysis]
4 Valentini CG, Metafuni E, Gallo L, Giammarco S, Orlando N, Bianchi M, Sica S, Bacigalupo A, Chiusolo P, Teofili L. ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes. Transplant Direct 2021;7:e724. [PMID: 34263022 DOI: 10.1097/TXD.0000000000001179] [Reference Citation Analysis]